Hikal Limited convened a Board of Directors meeting on October 1, 2026, with the outcome disclosed to the National Stock Exchange at 13:27 IST. The announcement follows a fiscal year in which the specialty chemicals and pharmaceutical ingredients manufacturer declared a combined dividend of ₹0.60 per equity share for FY2025-26, comprising an interim dividend of ₹0.20 per share (February 11, 2026) and a final dividend of ₹0.40 per share (May 27, 2026).

Dividend Details: FY26 Payout

The FY2025-26 total dividend of ₹0.60 per equity share (face value ₹2 per share, ISIN: INE475B01014) marks a significant contraction from the prior fiscal year. In FY2024-25, Hikal had distributed a total of ₹1.40 per share, composed of an interim dividend of ₹0.60 (February 4, 2025) and a final dividend of ₹0.80 (May 14, 2025). The FY26 payout therefore represents a 57.1% year-on-year decline in total dividend per share.

Dividend History and Trend Analysis

A review of Hikal's dividend announcements over the past five fiscal years reveals a clear downward trajectory in total annual payouts after peaking in FY2021-22:

The FY26 payout is the lowest in this five-year window, with the interim component alone having fallen from ₹0.60 to ₹0.20, a reduction of 66.7% on a like-for-like basis. The final dividend of ₹0.40 matches the FY22 final payout but is half the ₹0.80 declared in FY25.

Dividend Yield Context

With NSE trade data unavailable at the time of this report, a precise dividend yield calculation requires referencing the last available price. Investors should note that at a hypothetical price of ₹200 per share, the FY26 total dividend of ₹0.60 would translate to a dividend yield of approximately 0.30%, which is modest relative to broader market benchmarks. Any material change in the stock price would alter this figure proportionately, and investors are advised to compute yield against the prevailing market price at the time of assessment.

Company Background

Hikal Limited is a Mumbai-headquartered specialty chemicals and contract research and manufacturing services (CRAMS) company serving the pharmaceutical and crop protection sectors. The company's equity shares are listed on both NSE and BSE under the symbol HIKAL.

What This Means for Investors

The sustained compression in Hikal's per-share dividend over FY26 is a data point that income-focused investors will need to weigh carefully. The reduction in the interim dividend from ₹0.60 to ₹0.20 suggests possible capital conservation priorities or earnings pressure during the first three quarters of FY26. The final dividend of ₹0.40, while unchanged from FY22 levels, does not compensate for the lower interim, bringing the full-year payout to a five-year low. Shareholders on record for the final dividend declared in May 2026 would have received ₹0.40 per share, subject to applicable tax deducted at source as per prevailing regulations.